Ozempic and Wegovy Injury Claims

Ozempic and Wegovy both contain semaglutide, a prescription medicine used for different FDA-approved indications. Rybelsus is another semaglutide product taken by mouth. People who experienced a serious injury while using semaglutide may have questions about what happened, what the product information said at the time, and whether a legal claim is available. Logue Law Group handles Ozempic and Wegovy injury matters and works with leading national mass-tort firms to evaluate and pursue claims. Each case is reviewed on its own facts; no outcome is promised.

Semaglutide products and potential injury claims

Ozempic is prescribed to adults with type 2 diabetes for blood-sugar control and certain risk-reduction indications. Wegovy is a semaglutide product approved for chronic weight management in eligible patients and for certain other indications. Although the medicines share an active ingredient, their labels, doses, indications, and individual medical circumstances may differ. A legal review should identify the exact product, dose, treatment dates, prescribing purpose, and warnings in effect during use.

People have reported serious conditions during or after semaglutide treatment. Reports and allegations are not proof that a medicine caused a particular person’s injury. A product-liability claim requires evidence, including a medical diagnosis and an analysis of causation, warnings, product design, and applicable law.

Injuries that may require careful review

Stomach-emptying problems and gastroparesis

Semaglutide slows gastric emptying. Some patients have experienced severe or persistent digestive symptoms, including nausea, vomiting, abdominal discomfort, dehydration, or diagnosed gastroparesis. The clinical question is not simply whether symptoms occurred after a dose: a medical professional must evaluate the condition, possible causes, medication history, and other relevant factors. A legal review may examine the product label and warnings, treatment course, records, and whether a complication required hospitalization, procedures, or lasting care.

Gallbladder and biliary conditions

Gallstones, gallbladder inflammation, and bile-duct problems can be serious. FDA prescribing information for semaglutide products includes warnings about acute gallbladder disease. Weight change, prior conditions, other medicines, and individual risk factors may also matter. If you had gallbladder treatment while taking a semaglutide medicine, preserve records of the diagnosis, imaging, surgery, and treatment dates for review.

Vision loss, NAION, and diabetic retinopathy

Sudden vision loss or rapidly worsening eyesight needs urgent medical evaluation. In June 2025, the European Medicines Agency’s safety committee concluded that non-arteritic anterior ischemic optic neuropathy (NAION) is a very rare side effect of semaglutide medicines and recommended product-information updates. In the United States, FDA prescribing information also describes diabetic-retinopathy complications observed in a clinical trial and recommends monitoring patients with a history of diabetic retinopathy. NAION and diabetic retinopathy are distinct conditions; a clinician must determine the diagnosis and potential causes. Learn more on our Ozempic and Wegovy vision-loss and NAION page.

Other severe or lasting complications

People may seek legal review after hospitalization, surgery, long-term treatment, permanent impairment, or death they believe is connected to semaglutide use. A report in a public adverse-event database cannot establish incidence or causation by itself. Our review focuses on the person’s actual diagnosis and records rather than assuming every side effect creates a lawsuit.

What a product-liability review examines

A potential claim may involve questions about whether product warnings were adequate, whether a product defect contributed to harm, and whether the drug’s manufacturer or another responsible party failed to meet a legal duty. The available legal theories and required proof vary by jurisdiction. An attorney may examine:

• Prescription and dispensing records, product name, dose, and dates of use
• Medical records documenting symptoms, diagnosis, treatment, and other possible causes
• Product labeling and safety information in effect during the relevant period
• Evidence about the injury’s severity, prognosis, expenses, lost income, and daily impact
• Time limits, venue, and procedural requirements that may apply to the claim

There is no single checklist that guarantees eligibility. A medical diagnosis, treatment records, and a timeline are useful starting points. Do not send confidential medical records through an unsecured channel; our team can explain how to submit information safely.

Steps to take after a serious injury

1. Seek medical care for urgent symptoms, including sudden changes in vision, persistent vomiting, severe abdominal pain, or dehydration.
2. Follow your treating clinician’s advice about medication and treatment. Do not start, stop, or change a prescription based only on website information.
3. Keep copies of prescriptions, pharmacy histories, medical records, test results, and bills.
4. Write down the medication name, approximate start and stop dates, dose changes, symptoms, and key medical visits.
5. Speak with a lawyer promptly about whether a claim may be available and what limitation periods apply.

How Logue Law Group approaches Ozempic and Wegovy cases

Logue Law Group handles Ozempic and Wegovy injury matters and works with leading national mass-tort firms on complex pharmaceutical litigation. We review each potential matter individually, including medical history, treatment timeline, claimed injury, and the applicable law. A review does not mean that a claim will be accepted, filed, or successful. If the facts and law support further action, counsel can explain the possible process, responsibilities, and fee terms before any representation is agreed.

There is no guaranteed settlement or fixed value for an Ozempic or Wegovy claim. Any recovery depends on evidence, injury, causation, damages, defenses, applicable law, and the outcome of negotiations or litigation. We do not publish a universal settlement estimate because it could be misleading.

Frequently asked questions

Can Ozempic or Wegovy cause vision loss?

In 2025, the EMA’s safety committee concluded that NAION is a very rare semaglutide side effect. FDA labeling separately addresses diabetic-retinopathy complications observed in a clinical trial. These are different conditions, and an individual’s diagnosis and causation require medical evaluation. Sudden vision loss needs urgent care.

Does every person with gastroparesis or gallbladder disease have a claim?

No. Diagnosis alone does not establish that a medicine caused an injury or that a legal claim can be brought. The medication history, medical evidence, product warnings, alternative explanations, injury impact, and state law all matter.

How long do I have to file?

Deadlines vary by state, claim type, and facts. Some time limits begin or are affected by when an injury was discovered or reasonably should have been discovered. Do not rely on a general website deadline; ask a lawyer to assess the rules that apply to your situation.

Will my consultation create an attorney-client relationship?

No. Contacting the firm or receiving general information does not by itself create an attorney-client relationship. Representation begins only after conflicts are checked and a written agreement is signed.

Contact Logue Law Group

If you or a family member experienced a serious condition during or after Ozempic or Wegovy use, contact Logue Law Group to request a confidential case review. We can discuss your medical timeline, the records that may help, and whether further evaluation is appropriate. Call (412) 387-6901 or contact us online.

Medical information and legal advertising notice: This page provides general information, not medical advice or a guarantee that a claim exists. Seek care from a qualified medical professional. Laws and deadlines differ by jurisdiction. Prior results do not guarantee a similar outcome.

Sources: Current FDA-approved WEGOVY prescribing information (revised June 2026); Current FDA-approved OZEMPIC prescribing information (revised July 2026); European Medicines Agency safety committee update on NAION (June 2025).

Ozempic injury pages for West Virginia communities

These guides cover gallbladder-related injuries and gastroparesis concerns for readers in Morgantown, Wheeling, and Wellsburg. They explain current medical information, describe how individual claims are evaluated, and link back to this overview.

• Morgantown: Ozempic and gallbladder injury claims
• Wheeling: Ozempic and gallbladder injury claims
• Wellsburg: Ozempic and gallbladder injury claims
• Morgantown: Ozempic and gastroparesis claims
• Wellsburg: Ozempic and gastroparesis claims
• Wheeling: Ozempic and gastroparesis claims

This information is general and does not determine whether a particular injury was caused by medication or whether a legal claim is available.

More semaglutide injury guides

These guides address reported semaglutide safety concerns and explain that an individual claim requires its own evidence review.

• Ozempic and Wegovy pancreatitis claims
• Ozempic and Wegovy kidney injury claims
• Ozempic and Wegovy ileus and bowel obstruction claims
• Ozempic and Wegovy aspiration during anesthesia claims
• Ozempic and Wegovy gallbladder and biliary injury claims
• Ozempic and Wegovy gastroparesis claims

For detailed statewide information, see our Ozempic and Wegovy gallbladder and biliary injury claims guide and our gastroparesis and delayed stomach-emptying guide. Each page links to current FDA labeling and explains that an individual claim requires its own evidence review.

Pennsylvania statewide Ozempic and Wegovy case reviews

Logue Law Group reviews serious Ozempic and Wegovy injury matters for people across Pennsylvania. The firm can discuss cases arising in Pittsburgh and western Pennsylvania, Philadelphia and the southeast, Harrisburg and central Pennsylvania, Erie and the northwest, Scranton and the northeast, and communities throughout the state. These are examples of statewide service coverage, not a representation that the firm maintains an office in each city. The place where a person lives or received care does not, by itself, determine whether a claim is available. Each matter requires review of the medication history, injury, records, applicable law, and any relevant deadlines.

For people in Pennsylvania and elsewhere, this overview links to guides on gastroparesis and delayed stomach emptying, vision loss and NAION, gallbladder and biliary conditions, and other reported semaglutide safety concerns above.